Zhitong Financial App News, Federal Pharmaceuticals (03933.HK) announced that the new drug clinical trial registration application (IND) for UBT48128 tablets, a Class 1 innovative drug independently developed by Federal Biotechnology (Zhuhai Hengqin) Co., Ltd., a wholly-owned subsidiary of the Company, for overweight or obesity and type 2 diabetes, was approved by the US Food and Drug Administration (FDA). The IND numbers are 182060 and 182061, respectively.

Zhitongcaijing · 3d ago
Zhitong Financial App News, Federal Pharmaceuticals (03933.HK) announced that the new drug clinical trial registration application (IND) for UBT48128 tablets, a Class 1 innovative drug independently developed by Federal Biotechnology (Zhuhai Hengqin) Co., Ltd., a wholly-owned subsidiary of the Company, for overweight or obesity and type 2 diabetes, was approved by the US Food and Drug Administration (FDA). The IND numbers are 182060 and 182061, respectively.